Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

genetic test

New Clinical Lab Trends To Shape Events in 2010

CEO SUMMARY: In presenting this list of macro trends for clinical laboratories, several themes are in play. They range from a continued emphasis on improving lab operations to the need to acquire and deploy sophisticated information technology. During the next few years, the long…

Read More



2009’s Top Ten Lab Stories Reflect Some Good, Bad

CEO SUMMARY: As the closing year of the first decade of the new century and the new millennium, 2009 brought neither disruption nor upheaval to the majority of laboratories in the United States. Rather, it was marked by at least two themes. One was how public disclosure of problems with l…

Read More



Physicians in Survey Recognize Lack of Genetic Test Knowledge

MOST PHYSICIANS BELIEVE they are inadequately informed about pharmacogenomics (PGx) and how to utilize genetic tests. That’s the finding of a survey of 10,303 physicians and reveals an opportunity for pathologists and clinical lab professionals to fill an unmet need. In fact, only 10% of the 10,30…

Read More



Textbook Marketing Fuels Demand for BRCA Test

CEO SUMMARY: In today’s lab testing marketplace, the hot ticket is to introduce a proprietary or patent-protected molecular test for cancer. The sales and marketing model inspiring many of these new lab testing companies is that used by Myriad Genetics, Inc. since it introduced…

Read More



CBL Path, Plus Diagnostics, Alpha Innotech, DNA Direct, Humana

NEW PATHOLOGY LABS OPEN ON EAST COAST TIMES MUST BE GOOD for anatomic pathology companies—at least two companies have each announced the opening of a new laboratory facility. On the East Coast, it was CBL Path, Inc., of Rye Brook, New York, which expanded. On May 29, it a…

Read More



June 08, 2009 “Intelligence: Late Breaking Lab News”

Earlier this spring, El Camino Hospital of Mountain View, California, announced the launch of what it calls the “Genetic Medicine Institute (GMI).” It claims it is the first hospital in the United States to “integrate genomic medicine into healthcare delivery.” El Camino will…

Read More



Biotech Start-Up Firms Hiring Lab Professionals

CEO SUMMARY: It may be a tough job market right now for laboratory professionals. But investors, lured by the potential of personalized medicine and molecular diagnostics, continue to pour investment capital into new companies. In turn, these companies are actively recruiting exp…

Read More



Puzzling New Flu Strain Causes Concern in Mexico

CEO SUMMARY: In recent weeks, health authorities in Mexico became aware of a new strain of influenza, A/H1N1, because of unexpected deaths from “atypical pneumonia.” As early as April 19, the CDC had identified similar cases in Texas and California. By last Friday, WHO, Canad…

Read More



Navigenics Buys Clinical Lab From Affymetrix Last Month

IF NAVIGENICS INC. HAD A SLOGAN to match its business model, it might be, “Damn the torpedoes. Full speed ahead!” Last month the personal genomics testing company acquired a clinical testing laboratory. In a deal with Affymetrix, Inc., Navigenics purchased the …

Read More



February 23, 2009 “Intelligence: Late Breaking Lab News”

Here’s an interesting development on the road to genetic medicine. In England last month, the press heralded the birth of what it has dubbed the “cancer-free” baby. It turns out the parents had the embryo screened for the BRCA-1 gene before implantation—and this was the first example known in…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;